VRCA Q2 2021 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

VRCAVerrica Pharmaceuticals Inc.

$57M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$94,000

Operating Income

-$11M

Net Income

-$12M

EPS (Diluted)

$-4.28

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$99M

Total Liabilities

$47M

Stockholders' Equity

$52M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$94,000	$0	—
Operating Income	-$11M	-$9M	-24.3%
Net Income	-$12M	-$9M	-25.1%